FEDERAL COURT OF AUSTRALIA
Reckitt Benckiser (Australia) Pty Ltd v GlaxoSmithKline Australia Pty Ltd [2018] FCAFC 138
Appeal from: GlaxoSmithKline Australia Pty Ltd v Reckitt Benckiser (Australia) Pty Limited (No 2) [2018] FCA 1 File number: NSD 292 of 2018 Judges: MCKERRACHER, YATES AND GLEESON JJ Date of judgment: 24 August 2018 Catchwords: CONSUMER LAW – comparative advertising of pain relief products in the treatment of common headaches, including tension-type headaches – whether advertising was misleading or deceptive, or likely to mislead or deceive – whether advertising made false representations Legislation: Australian Consumer Law (Sch 2 of the Competition and Consumer Act 2010 (Cth)), ss 4, 18, 29 Cases cited: Waterways Authority v Fitzgibbon [2005] HCA 57; (2005) 221 ALR 402 Date of hearing: 20 August 2018 Registry: New South Wales Division: General Division National Practice Area: Commercial and Corporations Sub-area: Regulator and Consumer Protection Category: Catchwords Number of paragraphs: 43 Counsel for the Appellant: Mr B Walker SC with Mr A R Vincent Solicitor for the Appellant: HWL Ebsworth Lawyers Counsel for the Respondents: Mr R Cobden SC with Mr H P T Bevan and Mr B Narula Solicitor for the Respondents: Bird & Bird ORDERS
NSD 292 of 2018 BETWEEN: RECKITT BENCKISER (AUSTRALIA) PTY LTD
Appellant
AND: GLAXOSMITHKLINE AUSTRALIA PTY LTD
First Respondent
GLAXOSMITHKLINE CONSUMER HEALTHCARE AUSTRALIA PTY LTD
Second Respondent
JUDGES:
MCKERRACHER, YATES AND GLEESON JJ
DATE OF ORDER:
24 AUGUST 2018
THE COURT ORDERS THAT:
1.The appeal be dismissed.
2.The parties have leave to file submissions on costs to be determined on the papers.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
REASONS FOR JUDGMENT
THE COURT:
INTRODUCTION AND BACKGROUND
The primary judge found that, by publishing certain advertising material, the appellant, Reckitt Benckiser (Australia) Pty Ltd (Reckitt) engaged in conduct that was misleading or deceptive, or likely to mislead or deceive, in contravention of s 18 of the Australian Consumer Law (ACL) and made false representations in contravention of ss 29(1)(a) and (g) thereof.
The advertising material comprised print advertising (including in store advertising) and a television commercial used in a comparative advertising campaign in which Reckitt compared its product Nurofen and its active ingredient ibuprofen with a competing product, Panadol and its active ingredient paracetamol (also called acetaminophen). The respondents, GlaxoSmithKline Australia Pty Ltd and GlaxoSmithKline Consumer Healthcare Australia Pty Ltd (Glaxo), are the suppliers of the competing product.
The primary judge found that representations to the following effect were made:
(a)Nurofen, and thus ibuprofen, when taken in the recommended dose and as directed by the manufacturer, generally delivers faster and more effective relief from pain caused by common headaches including tension-type headaches (TTH) than Panadol or paracetamol.
(b)For the reasons stated in (a), Nurofen is better than Panadol and paracetamol for the treatment of common headaches including TTH and performs in a superior manner to Panadol and paracetamol in delivering pain relief for such headaches.
Keep reading for free
Create a free CaseChat account to read Reckitt Benckiser (Australia) Pty Ltd v GlaxoSmithKline Aust... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2018] FCAFC 138
- Decision Date
CaseChat Overview and Summary
The legal issues before the court were whether the advertising conducted by GlaxoSmithKline was indeed misleading or deceptive, or likely to mislead or deceive, and if it made any false representations. The court had to consider the advertising's accuracy, the context in which it was presented, and whether it could reasonably lead consumers to form a particular belief or impression about the advertised products.
In delivering the judgment, the court examined the content and context of the advertising in question. It assessed whether the claims made in the advertisements were supported by evidence and whether they could be interpreted in a misleading manner by consumers. The court determined that the advertising did not contain any misleading or deceptive statements or false representations. It found that the claims made were substantiated and that the context of the advertising did not lead to a misleading interpretation by consumers. Consequently, the appeal by Reckitt Benckiser was dismissed.
The court also granted leave to the parties to file submissions on costs to be determined on the papers, in accordance with Rule 39.32 of the Federal Court Rules 2011.
Orders
Orders of the court
1. The appeal be dismissed.
2. The parties have leave to file submissions on costs to be determined on the papers.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi